The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19

University of Ioannina

Status: Unknown

Conditions: Vaccination; Covid19; Kidney Transplantion; End Stage Kidney Disease

Treatments: Biological: SARS - COV 2 VACCINE

Study type: Observational

Funder types: Other

Identifiers

NCT04932876

RESCOMUOI82152

Details and patient eligibility

About

Observational study of patients with End Stage Kidney Disease on dialysis and Kidney Transplant Recipients, before and after vaccination for SARS-COV 2, after written consent, with the aim of laboratory efficacy of the vaccine and safety regarding the clinical outcome of patients and possible complications.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age >18 years
• Covid 19 vaccination

Exclusion criteria

• previous covid infection
• recent infection
• chronic infection
• HBV, HCV, HIV
• Active malignancy

Trial design

100 participants in 2 patient groups

ESKD - HD

Description:

End Stage Kidney Disease on Long Term Dialysis

Treatment:

Biological: SARS - COV 2 VACCINE

KTR

Description:

Kidney Transplant Recipient

Treatment:

Biological: SARS - COV 2 VACCINE